scholarly journals Mechanism of Aminoglycoside Antibiotic Resistance in Anaerobic Bacteria: Clostridium perfringens and Bacteroides fragilis

1979 ◽  
Vol 15 (1) ◽  
pp. 7-13 ◽  
Author(s):  
L. E. Bryan ◽  
S. K. Kowand ◽  
H. M. Van Den Elzen
1979 ◽  
Vol 9 (5) ◽  
pp. 627-628
Author(s):  
D A Casciato ◽  
J E Rosenblatt

The survival of six species of anaerobic bacteria was studied in simple or commercially available diluents. Bacteroides fragilis and Fusobacterium nucleatum showed excellent survival in all diluents including distilled water. Fusobacterium mortiferum survived well in all diluents except water and water supplemented with 0.1% gelatain. Clostridium perfringens survived best in phosphate-buffered saline with gelatin. Peptococcus asaccharolyticus required gelatin added to the basic diluent, and Streptococcus intermedius showed excellent survival only in minimal essential medium with gelatin. These diluents could provide effective and economical alternatives to more complex and costly diluents often used in work with anaerobic bacteria.


1979 ◽  
Vol 25 (9) ◽  
pp. 987-990 ◽  
Author(s):  
James E. Ogg ◽  
Sun Y. Lee ◽  
Betty J. Ogg

A new type of tube (the Lee tube) has been developed for use in the cultivation and enumeration of obligate anaerobes. The Lee tube is a double-walled, screw-capped tube which allows the formation of a thin cylinder of agar medium between the two walls. Anaerobiosis is achieved through deoxygenation of the deep cylinder of agar during sterilization, a minimum of head space, and use of a reducing agent to absorb oxygen introduced during the inoculation procedure. For several species of Clostridium, Bacteroides fragilis, Fusobacterium necrophorum, Veillonella alcalescens, and Pectinatus cerevisiiphilus, colony counts of cultures in the Lee tubes were comparable with those obtained in pour plates incubated in a BBL GasPak system and in anaerobic roll tubes.


2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Anna Kędzia ◽  
Andrzej W. Kędzia

Introduction. Abies whitebark (Abies sibirica L.) belonging to the family Pinaceae. The tree grown in Mongol, China and Siberian taiga. Produced the pichtae oil, which is obtained by hydrodistillation method. It contain: α-pinene, β-pinene, β-caryophyllene, bornyl acetate, camphene, mircene and cineole. The oil exhibiting expectorant, analgesic, anti-inflammatory, antialergic, liver restorative, adaptogenic and antioxidant properties. It has antimicrobial activity. Aim. The aim of the date was to determine the susceptibility of anaerobic bacteria isolated from patients to pichtae oil. Material and methods. The investigated 49 strains of bacteria isolated from patients from genus Bacteroides (7 strains), Parabacteroides (1), Prevotella (8), Porphyromonas (5), Tannerella (1), Fusobacterium (6), Finegoldia (4), Parvimonas (2), Peptostreptococcus (4), Actinomyces (4), Bifidobacterium (1), Propionibacterium (6), and 10 reference strains. The concentrations the oil were the following: 2.5, 5.0, 7.5, 10.0, 15.0 and 20.0 mg/ml. The pichtae oil was added to Brucella agar with 5% defibrynated sheep blood, menadione and hemin. Inoculum containing 106 CFU/ml was seeded with Steers replicator upon the agar with oil or without oil (strains growth control). The incubation was carried out in anaerobic jars containing 10% C02 , 10% H2 and 80% N2 , palladic catalyst and anaerobic indicator, at 37°C for 48 hrs. The MIC was defined as the lowest concentration of the pichtae oil that completely inhibited growth the anaerobic bacteria. Results. The results investigation indicated that from Gram-negative rods Tannerella forsythia (MIC = 5.0 mg/ml), Bacteroides fragilis and Bacteroides uniformis (MIC = 7.5 mg/ml) were the most susceptible to pichtae oil. The growth of Prevotella strains were inhibited by concentrations in ranges 5.0-15.0 mg/ml. The Prevotella bivia (MIC 10.0-15.0 mg/ml) and Prevotella buccalis (MIC = 15.0 mg/ml) were the most resistant. The tested oil was active on account genus of Fusobacterium strains in concentrations 5.0-10.0 mg/ml. The Gram-positive cocci were the more sensitive then rods. The growth was inhibited by concentrations in ranges ≤ 2.5-10.0 mg/ml. The oil was equally effective against Gram-positive rods (MIC ≤ 2.5-10.0 mg/ml). From this bacteria the more susceptible were the strains of Actinomyces (MIC ≤ 2.5-7.5 mg/ml) and the least a rods from genus of Bifidobacterium (MIC = 10.0 mg/ml). The date indicated, that the Gram-positive anaerobes were the more susceptible to pichtae oil than Gram-negative rods. Conclusions. From among the Gram-negative bacteria the more susceptible to pichtae oil were the rods from genus Tannerella forsythia, Bacteroides fragilis and Bacteroides uniformis. Gram-positive anaerobic cocci were the more susceptible then Gram-positive rods. The pichtae oil was the more active towards Gram-positive bacteria then Gram-negative anaerobic rods.


1996 ◽  
Vol 40 (9) ◽  
pp. 2232-2235 ◽  
Author(s):  
H M Wexler ◽  
E Molitoris ◽  
D Molitoris ◽  
S M Finegold

The antimicrobial activity of trovafloxacin for 557 strains of anaerobic bacteria was determined by the National Committee for Clinical Laboratory Standards-approved Wadsworth agar dilution technique. The species tested included Bacteroides fragilis (n = 91), other members of the B. fragilis group (n = 130), Campylobacter gracilis (n = 15), other Bacteroides spp. (n = 16), Prevotella spp. (n = 49), Porphyromonas spp. (n = 15), Fusobacterium spp. (n = 62), Bilophila wadsworthia (n = 24), Sutterella wadsworthensis (n = 21), Clostridium spp. (n = 61), Peptostreptococcus spp. (n = 38), and gram-positive non-spore-forming rods (n = 35). Trovafloxacin inhibited all strains of B. fragilis at < or = 0.5 microgram/ml, 99% of other B. fragilis group species at < or = 2 micrograms/ml, and 96% of all anaerobes tested at < or = 2 micrograms/ml.


2011 ◽  
Vol 55 (7) ◽  
pp. 3616-3620 ◽  
Author(s):  
Diane M. Citron ◽  
Kerin L. Tyrrell ◽  
Vreni Merriam ◽  
Ellie J. C. Goldstein

ABSTRACTNXL104, a novel β-lactamase inhibitor, was tested at a constant concentration of 4 μg/ml in combination with ceftazidime (CAZ), with and without added metronidazole, against 396 β-lactamase-producing strains of anaerobic bacteria. MIC50/MIC90values forBacteroides fragilisand theB. fragilisgroup were 8/16 and 64/>128 μg/ml, respectively. Although CAZ-NXL104 had limited activity against most anaerobic strains, in combination with metronidazole it shows potential for treating mixed infections involving resistantEnterobacteriaceaeand anaerobes.


1988 ◽  
Vol 22 (Supplement_A) ◽  
pp. 63-71 ◽  
Author(s):  
Francis P. Tally ◽  
George J. Cuchural Jr.

2020 ◽  
Vol 66 (6) ◽  
pp. 389-399 ◽  
Author(s):  
Hye-In Jang ◽  
Ki-Jong Rhee ◽  
Yong-Bin Eom

The rapid increase in antibiotic resistance has prompted the discovery of drugs that reduce antibiotic resistance or new drugs that are an alternative to antibiotics. Plant extracts have health benefits and may also exhibit antibacterial and antibiofilm activities against pathogens. This study determined the antibacterial and antibiofilm effects of α-humulene extracted from plants against enterotoxigenic Bacteroides fragilis, which causes inflammatory bowel disease. The minimum inhibitory concentration and biofilm inhibitory concentration of α-humulene for B. fragilis were 2 μg/mL, and the biofilm eradication concentration was in the range of 8–32 μg/mL. The XTT reduction assay confirmed that the cellular metabolic activity in biofilm rarely occurred at the concentration of 8–16 μg/mL. In addition, biofilm inhibition by α-humulene was also detected via confocal laser scanning microcopy. Quantitative real-time polymerase chain reaction (qPCR) was also used to investigate the effect of α-humulene on the expression of resistance–nodulation–cell division type multidrug efflux pump genes (bmeB1 and bmeB3). According to the results of qPCR, α-humulene significantly reduced the expression of bmeB1 and bmeB3 genes. This study demonstrates the potential therapeutic application of α-humulene for inhibiting the growth of B. fragilis cells and biofilms, and it expands the knowledge about biofilm medicine.


Sign in / Sign up

Export Citation Format

Share Document